Amarillo Heart Clinical Research Institute — Amarillo, Texas

Amarillo Heart Clinical Research Institute is a clinical research site located in Amarillo, Texas, United States 79124.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Amarillo Heart Clinical Research Institute has participated in 19 clinical trials with 6 currently active.

Therapeutic areas: Percutaneous Coronary Intervention, Peripheral Endovascular Intervention, Atherosclerotic Cardiovascular Disease (ASCVD).

Sponsors: Duke University, Eli Lilly and Company, Janssen Research & Development, LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Amarillo

Browse all research sites in Texas · View every site in Amarillo

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Amarillo Heart Clinical Research Institute?

Amarillo Heart Clinical Research Institute has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Amarillo Heart Clinical Research Institute conducted?

Amarillo Heart Clinical Research Institute has 19 clinical trials on record, with 6 currently active. Their work covers Percutaneous Coronary Intervention, Peripheral Endovascular Intervention, Atherosclerotic Cardiovascular Disease (ASCVD).

Is Amarillo Heart Clinical Research Institute accredited by Crixeo Clinical Trials?

Amarillo Heart Clinical Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Amarillo Heart Clinical Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.